Although leptin therapy has been shown to reverse metabolic and neuroendocrine dysfunctions in obese individuals with congenital leptin deficiency, most cases of common obesity are associated with resistance to elevated levels of endogenous leptin, and to exogenously delivered leptin as well (Bluher and Mantzoros, 2009). The gene discussed is LEP; the disease is obesity disorder.